Finance

Lists
WAVE:CVE
Waverley Pharma Inc
0,010 CA$
0,00%
(0,00) 1D
9 қаз., 11:21:02 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for WAVE...
Mkt. cap
540,00 м.
Avg. vol.
1,33 мың
Volume
0,00
52-wk high
0,04 CA$
52-wk low
0,01 CA$
EPS
-0,01 CA$
Beta
0,45
Shares outstanding
54,00 млн
Mkt. cap
540,00 м.
Avg. vol.
1,33 мың
Volume
0,00
52-wk high
0,04 CA$
52-wk low
0,01 CA$
EPS
-0,01 CA$
Beta
0,45
Shares outstanding
54,00 млн
News stories
From web sources and news partners
About Waverley Pharma Inc
CEO-
Employees-
Founded2014
HeadquartersВиннипег, Манитоба, Канада
Sector-
Websitewaverleypharma.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
275,66 м.
297,00 м.
287,13 м.
314,47 м.
Cost of goods sold
206,97 м.
178,23 м.
193,54 м.
202,42 м.
Cost of revenue
206,97 м.
178,23 м.
193,54 м.
202,42 м.
Research and development expenses
12,00 мың
350,00
-
1,09 мың
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
245,00 м.
270,08 м.
216,44 м.
208,81 м.
Operating expense
256,99 м.
270,43 м.
216,44 м.
209,90 м.
Total operating expenses
463,96 м.
448,66 м.
409,98 м.
412,33 м.
Operating income
-188,30 м.
-151,66 м.
-122,85 м.
-97,86 мың
Other non operating income
-441,00
69,00
-30,00
-53,00
EBT including unusual items
-236,36 м.
-197,31 м.
-165,47 м.
-143,67 м.
EBT excluding unusual items
-236,36 м.
-197,31 м.
-165,47 м.
-143,67 м.
Income tax expense
1,63 мың
-
-
-
Effective tax rate
-0,69%
-
-
-
Other operating expenses
-
-
-
-
Net income
-237,99 м.
-197,31 м.
-165,47 м.
-143,67 м.
Net profit margin
-86,33%
-66,43%
-57,63%
-45,69%
Earnings per share
-
-
-
-
Interest and investment income
-
24,00
2,36 мың
-
Interest expense
-47,72 мың
-45,90 мың
-44,72 мың
-46,44 мың
Net interest expenses
-47,72 мың
-45,88 мың
-42,37 мың
-46,44 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-167,78 м.
-137,19 м.
-102,41 м.
-77,24 мың
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары